CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity
about
Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosisBasic residues in azurocidin/HBP contribute to both heparin binding and antimicrobial activityCAP37-derived antimicrobial peptides have in vitro antiviral activity against adenovirus and herpes simplex virus type 1CAP37 activation of PKC promotes human corneal epithelial cell chemotaxisSynthetic bactericidal peptide based on CAP37: a 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytesThree human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pterChemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic AgentsTwo mutants of human heparin binding protein (CAP37): toward the understanding of the nature of lipid A/LPS and BPTI bindingAmino acid sequence of CAP37, a human neutrophil granule-derived antibacterial and monocyte-specific chemotactic glycoprotein structurally similar to neutrophil elastaseCombined boyden-flow cytometry assay improves quantification and provides phenotypification of leukocyte chemotaxisInteractome analysis of longitudinal pharyngeal infection of cynomolgus macaques by group A Streptococcus.Increased plasma levels of heparin-binding protein in patients with acute respiratory distress syndrome.Bioactive Antimicrobial Peptides as Therapeutics for Corneal Wounds and Infections.Candidacidal activity of synthetic peptides based on the antimicrobial domain of the neutrophil-derived protein, CAP37Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal boneNeutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of miceCorneal wound healing, a newly identified function of CAP37, is mediated by protein kinase C delta (PKCĪ“).Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate.Antibiotic proteins of human neutrophils.A multifunctional peptide based on the neutrophil immune defense molecule, CAP37, has antibacterial and wound-healing propertiesCAP37, a novel inflammatory mediator: its expression in endothelial cells and localization to atherosclerotic lesions.Neutrophils: the forgotten cell in JIA disease pathogenesisThe antimicrobial protein, CAP37, is upregulated in pyramidal neurons during Alzheimer's disease.Spontaneous pmrA mutants of Salmonella typhimurium LT2 define a new two-component regulatory system with a possible role in virulence.The proteomic profile of circulating pentraxin 3 (PTX3) complex in sepsis demonstrates the interaction with azurocidin 1 and other components of neutrophil extracellular trapsInhibition of tumor growth by elimination of granulocytes.Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils.Suilysin Stimulates the Release of Heparin Binding Protein from Neutrophils and Increases Vascular Permeability in Mice.Neutrophil-derived azurocidin alarms the immune system.Heparin-binding protein: a key player in the pathophysiology of organ dysfunction in sepsis.Modulation of lipopolysaccharide-induced monocyte activation by heparin-binding protein and fucoidanBactericidal activities of synthetic human leukocyte cathepsin G-derived antibiotic peptides and congeners against Actinobacillus actinomycetemcomitans and Capnocytophaga sputigena.Human neutrophil azurocidin synergizes with leukocyte elastase and cathepsin G in the killing of Capnocytophaga sputigena.Structure of the azurocidin, proteinase 3, and neutrophil elastase genes. Implications for inflammation and vasculitis.Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation-enhancing LPS-induced cytokine release from monocytes.Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis.Heparin-binding protein (HBP) improves prediction of sepsis-related acute kidney injury.Lung endothelial heparan sulfates mediate cationic peptide-induced barrier dysfunction: a new role for the glycocalyx.Possible involvement of heparin-binding protein in transfusion-related acute lung injury.Azurocidin levels in maternal serum in the first trimester can predict preterm prelabor rupture of membranes.
P2860
Q22010613-E5FF1077-5AFB-4686-8F93-39AAC263251EQ24296762-DA3F619E-7247-4497-9C31-858F521E894EQ24319488-A5C600D4-9B95-438A-AC28-0E8E3E621B8BQ24322780-BF2DA402-6D36-4F5B-B6C8-056DF6F625C5Q24562889-CA8A63F4-8586-4761-ADB9-55DABF97D48DQ24564102-D7E8AC97-3FD7-4A7E-A347-DF3D5F583DE7Q26830743-1C49BA89-DAA3-4B48-AD60-35804913FE5AQ27629371-2C3D35FC-0256-4E75-99E6-A10746231F1CQ28257912-5AC015C0-3DAD-4762-A40C-4B07D51B8B34Q28741642-BFD8C578-1234-4FCF-A62B-525A52788FEFQ33740683-83E03EC1-383B-4AAE-85E6-616761C5BC2AQ33751983-8D0851D0-6485-478F-8A96-8D27AFCD6AF5Q33786232-4E861268-1646-461E-9A2E-444B70891D4DQ33927464-809BBFC8-2767-4195-A705-78D26B825C49Q34000267-9A8178C2-C271-44A4-9313-BF0C095B3B15Q34003207-A4DB6F68-974F-4DA0-9609-6A9FDC638210Q34020741-5E4D95BB-A8AF-4943-A0AC-F3911F3348ECQ34212308-B3D226EC-D851-41C3-9D77-B9B1A5DCB9E0Q34262671-9FAD3B90-2C19-4D33-933B-883BFBB7B8D5Q35005890-A30B4EEA-1643-4CA8-9252-3AC600E1F7CBQ35788772-988633F9-16D8-4993-B567-EEB2F6EAFBF7Q35865602-E0FC535F-8420-4277-AEA9-5FC354EC4D00Q36073680-423D9992-0129-4A60-B82E-1F4AD5C1EB1FQ36102441-86D4E3A8-7D0B-4CCA-8B57-0B14B426F4CDQ36209095-37E9A059-62EC-4A2C-AC25-47709BEDA398Q36364220-9213B234-5989-439F-BDDF-286DEE732A4EQ36380472-B2ABE4AF-4441-4714-B0BE-A8B314B45B39Q37208227-B45E7A8D-8BD6-4C05-9019-F2E4464E41D2Q37310038-A9145B84-C788-4E91-9D01-B7F142D3B17FQ39216062-0248996C-4F2A-4923-9913-2AF4B9DE9276Q39573997-FB711577-C603-4CB1-AB56-4A8AD011D58CQ39883789-4562BA07-6DA7-4936-92E3-015F505196EAQ40152365-BB6CB4BE-A9CE-4BC7-A3FC-214590854D82Q41009953-63A69411-56B1-4DB7-BF65-FB9552AAC6DEQ41184636-555031D8-BC51-4432-BA63-6A6A207C6581Q41836488-CC3E7244-0AB3-494D-A481-5AA7C40C6F42Q42677894-3DD22C5D-6A58-4E22-B97C-606BCD255277Q44445819-3E56EF3F-EA64-4426-A710-23638AEBB12DQ50656014-AC8F6400-4B39-401B-A533-31CD74014828Q50871616-225FB030-3729-4DAA-955C-2871CE4A8442
P2860
CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity
description
1990 nĆ® lÅ«n-bĆ»n
@nan
1990 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« ÕÕ”ÕµÕ«Õ½Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
1990 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ“Õ”ÕµÕ«Õ½Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
1990幓ć®č«ę
@ja
1990幓č«ę
@yue
1990幓č«ę
@zh-hant
1990幓č«ę
@zh-hk
1990幓č«ę
@zh-mo
1990幓č«ę
@zh-tw
1990幓č®ŗę
@wuu
name
CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity
@ast
CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity
@en
CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity
@nl
type
label
CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity
@ast
CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity
@en
CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity
@nl
prefLabel
CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity
@ast
CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity
@en
CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity
@nl
P2093
P2860
P3181
P356
P1476
CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity
@en
P2093
H A Pereira
J K Spitznagel
L E Martin
W M Shafer
P2860
P304
P3181
P356
10.1172/JCI114593
P407
P577
1990-05-01T00:00:00Z